Observations on the Desert Tortoise

This is where the abstract of this record would appear. This is only demonstration data

Complete genome sequence of Syntrophobacter fumaroxidans strain (MPOB(T)).

Syntrophobacter fumaroxidans strain MPOB(T) is the best-studied species of the genus Syntrophobacter. The species is of interest because of its anaerobic syntrophic lifestyle, its involvement in the conversion of propionate to acetate, H2 and CO2 during the overall degradation of organic matter, and its release of products that serve as substrates for other microorganisms. The strain is able to ferment fumarate in pure culture to CO2 and succinate, and is also able to grow as a sulfate reducer with propionate as an electron donor. This is the first complete genome sequence of a member of the genus Syntrophobacter and a member genus in the family Syntrophobacteraceae. Here we describe the features of this organism, together with the complete genome sequence and annotation. The 4,990,251 bp long genome with its 4,098 protein-coding and 81 RNA genes is a part of the Microbial Genome Program (MGP) and the Genomes to Life (GTL) Program project

Modelling road hazards and the effect on AV safety of hazardous failures

Autonomous vehicles (AV) are about to appear on our roads within the next few years. However, to achieve the final breakthrough, not only functional progress is required, but also fundamental safety questions must be solved. Among those, a question demanding special attention is the need to assess the overall safety of an AV and quantify that it is safe enough to take part in normal traffic despite its inherent imperfections. Therefore, this paper describes a probabilistic model, which allows to study how imperfections of an AV perception system and of mechanisms responsible for AV safety (e.g., Safety Monitors), can impact AV safety in the presence of road hazards. We also demonstrate how the model can be used to validate if the AV is safe enough, to understand the criticality of (perception) errors, and to identify areas/parameters that have more influence on safety than others

Emprego da Ecocardiografia Convencional na Avaliaçao de Pacientes com Miocardiopatia Dilatada, candidatos à Terapia de Ressincronizaçao

O advento da ressincronizaçao cardíaca (RC) representou um enorme avanço no campo da terapêutica da insuficiência cardíaca. No entanto, aproximadamente 30% dos pacientes nao respondem à RC, o que pode estar relacionado aos critérios de seleçao. A ecocardiografia-doppler convencional vem auxiliando na seleçao dos possíveis candidatos à RC, no ajuste da programaçao para cada paciente e na avaliaçao dos resultados agudos e a longo prazo

Emprego da Ecocardiografia Convencional na Avaliaçao de Pacientes com Miocardiopatia Dilatada, candidatos à Terapia de Ressincronizaçao

O advento da ressincronizaçao cardíaca (RC) representou um enorme avanço no campo da terapêutica da insuficiência cardíaca. No entanto, aproximadamente 30% dos pacientes nao respondem à RC, o que pode estar relacionado aos critérios de seleçao. A ecocardiografia-doppler convencional vem auxiliando na seleçao dos possíveis candidatos à RC, no ajuste da programaçao para cada paciente e na avaliaçao dos resultados agudos e a longo prazo

A randomized comparative study of patients undergoing myocardial revascularization with or without cardiopulmonary bypass surgery: The MASS III Trial

The MASS III Trial is a large project from a single institution, The Heart Institute of the University of Sao Paulo, Brazil (InCor), enrolling patients with coronary artery disease and preserved ventricular function. The aim of the MASS III Trial is to compare medical effectiveness, cerebral injury, quality of life, and the cost-effectiveness of coronary surgery with and without of cardiopulmonary bypass in patients with multivessel coronary disease referred for both strategies. The primary endpoint should be a composite of cardiovascular mortality, cerebrovascular accident, nonfatal myocardial infarction, and refractory angina requiring revascularization. The secondary end points in this trial include noncardiac mortality, presence and severity of angina, quality of life based on the SF-36 Questionnaire, and cost-effectiveness at discharge and at 5-year follow-up. In this scenario, we will analyze the cost of the initial procedure, hospital length of stay, resource utilization, repeat hospitalization, and repeat revascularization events during the follow-up. Exercise capacity will be assessed at 6-months, 12-months, and the end of follow-up. A neurocognitive evaluation will be assessed in a subset of subjects using the Brain Resource Center computerized neurocognitive battery. Furthermore, magnetic resonance imaging will be made to detect any cerebral injury before and after procedures in patients who undergo coronary artery surgery with and without cardiopulmonary bypass

Measurement of the Higgs boson width and evidence of its off-shell contributions to ZZ production

Since the discovery of the Higgs boson in 2012, detailed studies of its properties have been ongoing. Besides its mass, its width—related to its lifetime—is an important parameter. One way to determine this quantity is to measure its off-shell production, where the Higgs boson mass is far away from its nominal value, and relating it to its on-shell production, where the mass is close to the nominal value. Here we report evidence for such off-shell contributions to the production cross-section of two Z bosons with data from the CMS experiment at the CERN Large Hadron Collider. We constrain the total rate of the off-shell Higgs boson contribution beyond the Z boson pair production threshold, relative to its standard model expectation, to the interval [0.0061, 2.0] at the 95% confidence level. The scenario with no off-shell contribution is excluded at a p-value of 0.0003 (3.6 standard deviations). We measure the width of the Higgs boson as ΓH=3.2−1.7+2.4MeV, in agreement with the standard model expectation of 4.1 MeV. In addition, we set constraints on anomalous Higgs boson couplings to W and Z boson pairs